Companies › INGN
INOGEN INC (INGN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001294133 · EDGAR filings · Updated 2026-07-24
INOGEN INC (INGN) has reported institutional ownership of 70.1%, with 126 institutional managers holding positions valued at $117.3M per the latest 13F reporting period.
Filings this week (1)
- 2026-07-24 — Employee-plan registration (S-8) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-09 — Insider transaction reported (Form 4)
- 2026-07-09 — Initial insider ownership filed (Form 3)
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-07-01 — Notice of proposed sale filed (Form 144)
- 2026-07-01 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, INOGEN INC has 126 institutional holders and institutional ownership of 70.1%.
Insider activity
Insiders reported 51 transactions (0 buys, 0 sells) across 12 reporting insiders, with a net reported value of $0.
Related companies
AGILON HEALTH INC (AGL) · THE ONCOLOGY INSTITUTE INC (TOI) · CLEARPOINT NEURO INC (CLPT) · AIRSCULPT TECHNOLOGIES INC (AIRS) · CYBIN INC (HELP) · Onkure Therapeutics Inc (OKUR)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.